Bajaj Healthcare (BHL) stock rose 6.32% with the authorization by India’s drug regulator to produce and commercialize lvejaj, a branded version of the generic antiparasitic…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.